Kristin Fiorino
Company: AstraZeneca
Job title: Director - Medical
Seminars:
9:30 am Evaluating Drug Safety Using Comprehensive Preclinical Assessments to Ensure Safer MASH Therapies 9:30 am
Employing comprehensive preclinical assessments so potential safety issues can be identified early in the drug development process to lead to safer MASH therapies for patients Utilizing a wide range of preclinical models and techniques to provide a thorough understanding of a drug’s potential toxicity profile to, minimize the risk of adverse events in clinical trials…Read more
day: Conf day 2